In the last trading session, 7.49 million Reviva Pharmaceuticals Holdings Inc. (NASDAQ:RVPH) shares changed hands as the company’s beta touched -0.11. With the company’s per share price at $1.14 changed hands at $0.34 or 42.50% during last session, the market valuation stood at $33.99M. RVPH’s last price was a discount, traded about -496.49% off its 52-week high of $6.80. The share price had its 52-week low at $0.60, which suggests the last value was 47.37% up since then. When we look at Reviva Pharmaceuticals Holdings Inc.’s average trading volume, we note the 10-day average is 1.07 million shares, with the 3-month average coming to 299.78K.
Analysts gave the Reviva Pharmaceuticals Holdings Inc. (RVPH) stock a consensus recommendation rating of Buy, calculated at a mean rating of 1.50. If we narrow down to specifics, the data shows that 0 out of 1 analysts rate the stock as a Sell, with a further 0 assigning it an Overweight rating. Of the remaining, 0 recommended RVPH as a Hold, 1 felt it is a Buy and 0 rated the stock as Underweight. Reviva Pharmaceuticals Holdings Inc.’s EPS for the current quarter is expected to be -0.28.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Reviva Pharmaceuticals Holdings Inc. (NASDAQ:RVPH) trade information
Instantly RVPH was in green as seen at the end of in last trading. With action 65.34%, the performance over the past five days has been green. The company’s shares are showing year-to-date downside of -77.86%, with the 5-day performance at 65.34% in the green. However, in the 30-day time frame, Reviva Pharmaceuticals Holdings Inc. (NASDAQ:RVPH) is 16.24% up. Looking at the short shares, we see there were 4.45 million shares sold at short interest cover period of 14.6 days.
Reviva Pharmaceuticals Holdings Inc. (RVPH) estimates and forecasts
Data shows that the Reviva Pharmaceuticals Holdings Inc. share is performing relatively much better than most of its peers within the same industry. As can be gleaned from the statistics, the company’s share value shot -74.03% over the past 6 months, a 40.61% in annual growth rate that is considerably higher than the industry average of 19.40%.
The 2024 estimates are for Reviva Pharmaceuticals Holdings Inc. earnings to increase by 35.39%.
RVPH Dividends
Reviva Pharmaceuticals Holdings Inc. is expected to release its next quarterly earnings report in September.
Reviva Pharmaceuticals Holdings Inc. (NASDAQ:RVPH)’s Major holders
If we look at who the major shareholders are, we find that insiders hold 16.58% of Reviva Pharmaceuticals Holdings Inc. shares while 24.03% of the shares are in the hands of institutional holders. The share float percentage for the stock currently stands at 28.81%. There are 24.03% institutions holding the Reviva Pharmaceuticals Holdings Inc. stock share, with WOODLINE PARTNERS LP the top institutional holder. As of 2024-03-31, the company held 4.3897% of the shares, roughly 1.06 million RVPH shares worth $3.99 million.
VANGUARD GROUP INC holds the second largest percentage of outstanding shares, with 4.1685% or 1.0 million shares worth $3.79 million as of 2024-03-31.
